TIGERMED
Hangzhou Tigermed Technology Co., Ltd. is a Chinese contract research organization providing whole process clinical trial services for the research and development of pharmaceutical products. Since its inception, the company is dedicated to the provision of medical research and development services that enables clients to reduce the risk and cost of R&D, while advancing the process of marketization. With 21 sub-companies spread across 43 main cities in the world, including China, America, C... anada, Japan, Australia, Korea, and more, Tigermed owns a professional team of more than 900 people that constructs the operating instruction that meets international standards. Tigermed has succeeded in providing more than 300 customers with over 300 clinical trial services by the end of 2013. For its participation in 42 domestic drugs, Tigermed is honoured as an “Innovation-type CRO.”
TIGERMED
Social Links:
Industry:
Biotechnology Clinical Trials Health Care Pharmaceutical
Founded:
2004-01-01
Address:
Hangzhou, Zhejiang, China
Country:
China
Website Url:
http://www.tigermed.net
Total Employee:
5001+
Status:
Active
Contact:
+86-571-28887227
Email Addresses:
[email protected]
Total Funding:
8.3 M USD
Technology used in webpage:
SPF LetsEncrypt Content Delivery Network Euro Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS CloudFront Java EE Google No Translate
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2015-10-01 | DreamCIS | DreamCIS acquired by Tigermed | N/A |
| 2014-05-08 | Frontage Laboratories | Frontage Laboratories acquired by Tigermed | 50.25 M USD |
Investors List
Qiming Venture Partners
Qiming Venture Partners investment in Venture Round - Tigermed
Qiming Venture Partners
Qiming Venture Partners investment in Series A - Tigermed
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-04-07 | LTZ Therapeutics | Tigermed investment in Seed Round - LTZ Therapeutics | 17 M USD |
| 2021-12-21 | BioInno | Tigermed investment in Series A - BioInno | N/A |
| 2021-11-15 | Jisi Yingda | Tigermed investment in Series B - Jisi Yingda | N/A |
| 2021-09-13 | CytoLynx Therapeutics | Tigermed investment in Funding Round - CytoLynx Therapeutics | 45 M USD |
| 2021-07-13 | Adlai Nortye | Tigermed investment in Series D - Adlai Nortye | 100 M USD |
| 2021-03-09 | Gmax Biopharm | Tigermed investment in Series C - Gmax Biopharm | 78 M USD |
| 2020-10-06 | Hinova Pharma | Tigermed investment in Series C - Hinova Pharma | 1000 M CNY |
| 2020-08-31 | Adlai Nortye | Tigermed investment in Series C - Adlai Nortye | 100 M USD |
| 2020-06-28 | Asieris Pharmaceuticals | Tigermed investment in Series C - Asieris Pharmaceuticals | 290 M CNY |
| 2020-02-18 | CANbridge Pharmaceuticals | Tigermed investment in Series D - CANbridge Pharmaceuticals | 98 M USD |
Official Site Inspections
http://www.tigermed.net Semrush global rank: 3.88 M Semrush visits lastest month: 3.31 K
Unable to get host informations!!!
More informations about "Tigermed"
Our Company - Tigermed
Since its inception in 2004, Tigermed (300347.SZ/3347.HK) has been a trusted clinical research organization that provides full-service for the global biopharmaceutical and medical device …See details»
Leadership - Tigermed
She joined Tigermed in July 2014, served as the General Manager of TigerYeah Investment, Vice President and Head of Tigermed Investment Bussiness Unit and has more than twenty years …See details»
Tigermed - Crunchbase Company Profile & Funding
Tigermed is a contract research company providing whole process clinical trial services for the R&D of pharmaceuticals. ... Contact Email [email protected]; Phone Number +86-571-28887227; Tigermed is a contract research …See details»
Tigermed - The Org
Tigermed (Stock code: 300347.SZ/3347.HK) is a leading provider of innovative clinical research solutions across the full life cycle of biopharmaceutical and medical device products globally. …See details»
Tigermed - LinkedIn
Tigermed (Stock code: 300347.SZ/3347.HK) is a leading provider of innovative clinical research solutions across the full life cycle of biopharmaceutical and medical device products globally.See details»
Tigermed Supported and Delivered Clinical Study of CanSino …
Feb 26, 2021 As a leading clinical contract research organization (CRO), Tigermed fully participated and supported multicenter phase III clinical study of Ad5-nCoV vaccine and was …See details»
Tigermed and Frontage Laboratories Announce Strategic …
May 8, 2014 Hangzhou Tigermed Consulting Co., Ltd. (stock symbol: 300347) is a leading Contract Research Organization (CRO) in China dedicated to provide professional full clinical …See details»
Tigermed Consulting Co., Ltd | Medidata Solutions
Tigermed (Stock code: 300347.SZ/3347.HK) is a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry. With a broad …See details»
Global Locations - Tigermed
Tigermed Services Philippines Inc. Clock in 6th floor service vertis north corporate center 1 Mindanao Avenue bagong Pag-Asa, Quezon City, Second District National Capital Region (NCR), 1105 . Philippines . Hongkong Tigermed Co., …See details»
Tigermed Officially Opens International Headquarters in Hong Kong
Aug 17, 2023 Tigermed (Stock code: 300347.SZ/3347.HK) is a preeminent global provider of integrated research and development solutions for the biopharmaceutical and medical device …See details»
Tigermed Forms Strategic Partnerships With Leading CROs in …
HANGZHOU, China, Nov. 24 /PRNewswire/ -- Tigermed Consulting Co., Ltd., a leading Contract Research Organization (CRO) in China, announced that it has established strategic …See details»
Tigermed Expands Clinical Trial Capabilities With Oracle Health ...
Jan 14, 2013 About Tigermed Hangzhou Tigermed Consulting Co., Ltd is a leading full service clinical stage Contract Research Organization (CRO) in China. For more information about …See details»
Tigermed Reports Strong 2021 Full-Year Results - PR Newswire
Mar 28, 2022 Mr. Hao Wu, Executive Director, and Co-President, said, "Tigermed is an organization with a unique culture that provides a distinctive experience and industry-leading …See details»
Press Releases - Tigermed
Adjusted Non-IFRS net profit attributable to owners increased by 60.6% YoY to RMB 1,585.3 million during the ... and Co-President, said, “Tigermed is an organization with a unique culture …See details»
Tigermed | Briefing, News, Analysis, Research, Data - EqualOcean
Dec 1, 2014 Tigermed, founded in December, 2014 and headquartered in Hangzhou, is a contract research organization (CRO) focused on providing professional services for the entire …See details»
Clinical CRO Tigermed: The ‘Small and Beautiful’ - EqualOcean
Jun 14, 2020 Tigermed makes revenue mainly from two principal businesses: clinical trial solutions and clinical-related services and laboratory services. The clinical trial solutions cover …See details»
Financial Reports and Presentations | Tigermed
Mar 28, 2024 Tigermed J.P.Morgan Healthcare Conference 2024 Presentation Read more . Oct 27, 2023 2023 THIRD QUARTERLY REPORT Read more . Aug 25, 2023 Tigermed 2023 …See details»
Hangzhou Tigermed Consulting Co., Ltd. Recognized for - Frost
-Hao Wu, Co-President, Tigermed . Tigermed envisions gradually transferring from a relatively labor-intensive model to a data powerhouse, anticipating clinical CRO market trends. Its in …See details»
Press Releases | Tigermed
Tigermed Insights . Resource Library . Cloud Classroom . Environment, Social and Governance (ESG) Sustainability & ESG Report . ESG Management . Corporate Responsibility . Corporate …See details»